bluebird bio inc (BLUE:NASDAQ GS)
Christof von Kalle M.D., Ph.D.
Member of Scientific Advisory Board, bluebird bio, Inc.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Prof. Dr. Christof Von Kalle MD, PhD serves as Chairman, department of Translational Oncology at German Cancer Research Center. Prof. Dr. Von Kalle serves as Director of National Center for Tumor Diseases at University Hospital Heidelberg. He has been Group Leader of Section of Hematopoiesis and Gene Transfer, Institute for Molecular Medicine, Freiburg University, Germany since 2000. He is trained in the areas of internal medicine, hematology and molecular biology. His ...
150 Second StreetPhone: 339-499-9300
Cambridge, Massachusetts 02141
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Edward O. Lanphier II||Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee|
Sangamo Biosciences Inc.
|David M. Pernock||Chairman of the Board, Chief Executive Officer and President|
Fibrocell Science, Inc.
|$490.0K||Compensation as of Fiscal Year 2014.|